Redcare Pharmacy NV reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 1,798.76 million compared to EUR 1,204.35 million a year ago. Net loss was EUR 12.04 million compared to EUR 77.65 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.5 EUR | -2.11% | -1.18% | -4.64% |
Apr. 26 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
Apr. 26 | REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating | ZD |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.64% | 2.78B | |
-33.93% | 14.86B | |
-23.66% | 11.73B | |
+16.46% | 6.3B | |
-25.24% | 6.29B | |
-9.39% | 6B | |
-2.34% | 4.63B | |
+60.00% | 4.57B | |
-8.19% | 3.5B | |
-6.41% | 3.04B |
- Stock Market
- Equities
- RDC Stock
- News Redcare Pharmacy NV
- Redcare Pharmacy NV Reports Earnings Results for the Full Year Ended December 31, 2023